Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

48.38 +0.38 (+0.80%)
Streaming Delayed Price Updated: 1:40 PM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sanofi - American Depositary Shares

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
39 40 Next >
News headline image
Revolution Medicines Regains Global Rights To Mid-Stage Cancer Program As Sanofi Terminates Collaboration ↗
 
Via Benzinga
News headline image
Fusion Fuel (HTOO) Stock Is Up 11% on HUGE Deal News ↗
Fusion Fuel (HTOO) stock is heading higher on Wednesday after the company secured a deal with the Portuguese government. 
Via InvestorPlace
News headline image
Why Is TransCode Therapeutics (RNAZ) Stock Up 148% Today? ↗
TransCode Therapeutics (RNAZ) stock is rallying higher on Wednesday after the company withdrew plans for a secondary offering. 
Via InvestorPlace
News headline image
SNY Stock Alert: Why 1 Analyst Says Zantac Ruling Is ‘Best-Case Scenario’ for Drugmakers ↗
Sanofi (SNY) stock is in the news as one analyst believes the latest court ruling is the "best-case scenario" for the drugmaker. 
Via InvestorPlace
News headline image
Meta Criticized For Providing Extra Protection To Certain Users, Twitter HQ Bedrooms Under Regulatory Scrutiny, Juul Settles Over 5,000 Lawsuits: Top Stories Wednesday, Dec. 07 ↗
Benzinga 
Via Benzinga
News headline image
Europe Approves Sanofi's Enjaymo For Rare Form Of Anemia ↗
 
Via Benzinga
News headline image
Relief To Pfizer, Sanofi As US Dismisses Several Lawsuits Associated With Zantac ↗
 
Via Benzinga
News headline image
These 3 Stocks Escaped Tuesday's Market Downdraft ↗
Even a dour outlook for the broader stock market couldn't outweigh good news for these companies. 
Via The Motley Fool
News headline image
Why GSK Plc And Sanofi SA Stock Are Shooting Higher ↗
Shares of GSK plc (NYSE: GSK) and Sanofi SA (NASDAQ: SNY) are trading higher going into the close of Tuesday's session after the companies reportedly won a Zantac product liability lawsuit. 
Via Benzinga
News headline image
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing
From Singapore Economic Development Board (EDB)A*STAR
Via ACN Newswire
News headline image
Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi ↗
There are now two companies in the ring for a Horizon takeover. 
Via Investor's Business Daily
News headline image
Stock Market Rally Fights At Key Level On Powell, Inflation Data, Jobs Report: Weekly Review ↗
The S&P 500 is fighting for its 200-day, a critical level for the uptrend. 
Via Investor's Business Daily
News headline image
If Sanofi Opted For Takeover Of Horizon Therapeutics, It Would Be In Cash ↗
 
Via Benzinga
News headline image
Why Horizon Therapeutics Stock Is Skyrocketing Today ↗
Three big drugmakers could be interested in acquiring Horizon. 
Via The Motley Fool
News headline image
Why Is Horizon Therapeutics (HZNP) Stock Up 30% Today? ↗
Horizon Therapeutics (HZNP) stock is rising higher on Wednesday following reports that the company is considering a buyout. 
Via InvestorPlace
News headline image
Are Tech Layoffs Going to Be a Headache for Alexandria Real Estate Equities? ↗
Tech layoffs are in the news, but life sciences companies seem to be doing better. 
Via The Motley Fool
News headline image
UK Drug Regulator Warns Of Severe Eye Reactions Associated With Sanofi/Regeneron's Dupixent ↗
 
Via Benzinga
News headline image
iPhone Pro Shipments May Miss Consensus, Tesla Rival Charts Ambitious Expansion Plan In Mexico, Amazon Cloud Unit To Add More Employees: Top Stories Wednesday, Nov. 30 ↗
Reuters 
Via Benzinga
News headline image
Horizon Therapeutics Shares Jump On Confirmation Of Takeover Talks With Several Large Companies ↗
 
Via Benzinga
News headline image
Horizon Therapeutics Rockets As It Considers Potential Bids From Amgen, J&J, Sanofi ↗
The three companies have until Jan. 10 to decide whether they want to buy Horizon. 
Via Investor's Business Daily
News headline image
First Drug That Can Delay Onset of Type 1 Diabetes Gets FDA Approval After Multiple Regulatory Hurdles ↗
 
Via Benzinga
News headline image
Daily Stock Analysis: Sanofi - November 2022 Snapshot ↗
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. The company's decided in late 2019 to pull back from the cardio-metabolic... 
Via Talk Markets
News headline image
A Paradigm Shift In Healthcare Produces A Big Market Opportunity ↗
In a couple of years, Dario Heath could easily be a $100M+ company running 60%+ gross margins, be profitable and cash generating. 
Via Talk Markets
News headline image
Eli Lilly's Twitter Fiasco Continues As Drugmaker Reportedly Pulls 'Millions' In Twitter Ads ↗
The fallout from a fake account continued Monday as Lilly reportedly pulled Twitter ads. 
Via Investor's Business Daily
News headline image
Can This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval? ↗
Learn More about Organicell Regenerative Medicine, Inc. by gaining access to the latest research report In the medical community, the popularity of regenerative medicine is reportedly soaring primarily... 
Via Benzinga
News headline image
Week In Review: Insilico Signs Six-Drug Discovery Deal With Sanofi Worth Up To $1.2 Billion ↗
Insilico Medicine signed a six-drug research collaboration with Sanofi that could be worth up to $1.2 billion. Insilico will receive up to $21.5 million in upfront and target nomination fees for each... 
Via Talk Markets
News headline image
2 Top Biotech Stocks to Buy in November ↗
Both of these companies have potential catalysts on the way. 
Via The Motley Fool
News headline image
Eli Lilly Dives After Fake Twitter Account Promises Free Insulin; Takes Novo Nordisk, Sanofi With It ↗
A fake, but verified, Twitter account impersonated Eli Lilly and claimed insulin is free. 
Via Investor's Business Daily
News headline image
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster ↗
 
Via Benzinga
News headline image
Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles ↗
Biogen jumped after naming Christopher Viehbacher its CEO. David Epstein will take over at Seagen. 
Via Investor's Business Daily
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.